Docusign Inc. (NASDAQ:DOCU – Get Free Report) Director Teresa Briggs sold 365 shares of the firm’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $50.04, for a total value of $18,264.60. Following the sale, the director directly owned 10,263 shares of the company’s stock, valued at $513,560.52. This represents a 3.43% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Docusign Price Performance
DOCU stock opened at $55.10 on Wednesday. The business has a fifty day moving average price of $47.41 and a 200 day moving average price of $54.53. Docusign Inc. has a fifty-two week low of $40.16 and a fifty-two week high of $94.67. The stock has a market capitalization of $10.71 billion, a price-to-earnings ratio of 37.23, a P/E/G ratio of 2.17 and a beta of 0.92.
Docusign (NASDAQ:DOCU – Get Free Report) last released its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. The company had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.86 earnings per share. On average, equities analysts expect that Docusign Inc. will post 1.76 earnings per share for the current fiscal year.
Key Headlines Impacting Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Docusign announced its app is now available in ChatGPT and Codex, extending its Intelligent Agreement Management platform into OpenAI products and potentially boosting adoption by making it easier for customers to create, analyze, and manage agreements with natural-language prompts. Docusign Brings Trusted Agreement Intelligence and Workflows into ChatGPT and Codex
- Positive Sentiment: The company also named Graham Sheldon as Chief Product Officer, a move aimed at accelerating its AI-focused product strategy and strengthening execution around its Intelligent Agreement Management vision. Docusign Appoints Graham Sheldon as Chief Product Officer to Accelerate Intelligent Agreement Management Vision
- Neutral Sentiment: Several directors disclosed stock sales, including Anna Marrs, James A. Beer, and Teresa Briggs. The transactions were relatively small and were executed under pre-arranged Rule 10b5-1 plans, which usually makes them less concerning for investors. SEC filing: Anna Marrs Form 4
- Neutral Sentiment: Investor attention is also focused on Docusign’s June 4 earnings report, with recent commentary suggesting the market wants proof that its AI-driven product strategy is translating into stronger execution. Dear Docusign Stock Fans, Mark Your Calendars for June 4
Institutional Investors Weigh In On Docusign
Institutional investors have recently made changes to their positions in the stock. Central Pacific Bank Trust Division acquired a new stake in shares of Docusign during the fourth quarter worth $25,000. Modus Advisors LLC acquired a new stake in shares of Docusign during the fourth quarter worth $27,000. Torren Management LLC acquired a new stake in shares of Docusign during the fourth quarter worth $28,000. True Wealth Design LLC grew its stake in shares of Docusign by 105.2% during the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares during the period. Finally, Aventura Private Wealth LLC acquired a new stake in shares of Docusign during the fourth quarter worth $30,000. 77.64% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
DOCU has been the subject of a number of recent research reports. HSBC set a $53.00 target price on Docusign in a research report on Friday, February 13th. Jefferies Financial Group downgraded Docusign from a “buy” rating to a “hold” rating and dropped their target price for the stock from $105.00 to $45.00 in a research report on Monday, February 23rd. UBS Group dropped their target price on Docusign from $75.00 to $54.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Bank of America initiated coverage on Docusign in a research report on Tuesday, March 31st. They set an “underperform” rating and a $52.00 target price for the company. Finally, Morgan Stanley dropped their target price on Docusign from $90.00 to $69.00 and set an “equal weight” rating for the company in a research report on Wednesday, March 18th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $61.40.
View Our Latest Stock Report on DOCU
Docusign Company Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Further Reading
- Five stocks we like better than Docusign
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
